Labetalol Intravenous and MenHibrix

• Generic Name: labetalol
• Dosage Forms: n.a.
• Other Brand Names: Trandate, Normodyne

Labetalol injection is used to treat severe high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also increase the risk of heart attacks. These problems may be less likely to occur if blood pressure is controlled .

Labetalol is a beta-blocker. It works by affecting the response to nerve impulses in certain parts of the body, like the heart. As a result, the heart beats slower and decreases the blood pressure. When the blood pressure is lowered, the amount of blood and oxygen is increased to the heart .

Labetalol is available only with your doctor's prescription .

• Generic Name: haemophilus b conjugate (prp-t) vaccine / meningococcal conjugate vaccine
• Dosage Forms: n.a.
• Other Brand Names: MenHibrix

MenHibrix vaccine is used to help prevent haemophilus B and meningococcal disease in children.

Haemophilus influenzae type B (Hib) is a bacteria that can cause serious illness, including breathing problems or meningitis. Hib infection usually affects children and can be fatal.

Meningococcal disease is a serious infection caused by a bacteria. Meningococcal bacteria can infect the blood, spinal cord, and brain, and can cause meningitis. These conditions can be fatal.

Haemophilus B and meningococcal disease can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes. The bacteria can also be passed through contact with objects the infected person has touched, such as a door handle, or other surface. The bacteria can also be passed through kissing, or sharing a drinking glass or eating utensil with an infected person.

MenHibrix works by exposing your child to a small dose of bacteria or a protein from the bacteria, which causes your body to develop immunity to the disease. MenHibrix will not treat an active infection that has already developed in the body.

MenHibrix is for use in children between the ages of 6 weeks and 18 months old.

Like any vaccine, MenHibrix may not provide protection from disease in every person.